Dungu, JN;
Papadopoulou, SA;
Wykes, K;
Mahmood, I;
Marshall, J;
Valencia, O;
Fontana, M;
... Anderson, LJ; + view all
(2016)
Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis.
Circulation: Heart Failure
, 9
(9)
, Article e003352. 10.1161/CIRCHEARTFAILURE.116.003352.
Preview |
Text
Fontana V122I Circ HF FINAL, Dungu et al.pdf - Accepted Version Download (980kB) | Preview |
Abstract
Background—It has been reported that subjects of African descent present with heart failure at a younger age and because of different causes than whites. We present contemporary data from UK Afro-Caribbean patients in London. Methods and Results—All patients with heart failure presenting to St George’s Hospital Heart Failure clinic between 2005 and 2012 were included (n=1392). Patients were predominantly white (71%) and male (67%), and median age at presentation was 73 years (range, 18–100 years). In 211 Afro-Caribbean patients, the most common cause of heart failure was nonischemic dilated cardiomyopathy in 27.5% (whites, 19.9%; P<0.001). Lower rates of ischemic cardiomyopathy were observed (13% versus 41%; P<0.001). The fourth most common cause of heart failure in Afro-Caribbeans was cardiac amyloidosis (11.4%). The prevalence may have been even higher as not all patients were tested for amyloidosis. Patients with ATTR V122I had the worst prognosis compared with other causes of Afro-Caribbean heart failure and white patients. To better understand this condition, we analyzed data from the largest international cohort of ATTR V122I patients, followed up at the UK National Amyloidosis Center (n=72). Patients presented with cardiac failure (median age, 75 [range, 59–90] years). Median survival was 2.6 years from diagnosis. Conclusions—In London, the cause of heart failure varies depending on ethnicity and affects age of presentation and outcomes. In Afro-Caribbean patients, ATTR V122I is an underappreciated cause of heart failure, and cardiomyopathy is often misattributed to hypertension. As promising TTR therapies are in development, increased awareness and proactive detection are needed.
| Type: | Article |
|---|---|
| Title: | Afro-Caribbean Heart Failure in the United Kingdom: Cause, Outcomes, and ATTR V122I Cardiac Amyloidosis |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1161/CIRCHEARTFAILURE.116.003352 |
| Publisher version: | https://doi.org/10.1161/CIRCHEARTFAILURE.116.00335... |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, amyloid, blacks, ethnology, heart failure, prognosis, LEFT-VENTRICULAR HYPERTROPHY, TRANSTHYRETIN ISOLEUCINE 122, AFRICAN-AMERICANS, BLOOD-PRESSURE, WILD-TYPE, BLACK-AMERICANS, OF-CARDIOLOGY, VARIANT, RECOMMENDATIONS, CARDIOMYOPATHY |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10042971 |
Archive Staff Only
 |
View Item |
